Company profile
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Roivant Sciences Ltd.
14 Feb 24
SC 13G/A
Roivant Sciences Ltd.
14 Feb 23
4
Dan Oren
14 Nov 22
4
Dan Oren
26 Apr 22
SC 13G
Roivant Sciences Ltd.
10 Feb 22
3
Dan Oren
1 Oct 21
SC 13G/A
Protalix BioTherapeutics, Inc.
15 Jun 21
4
Dan Oren
3 Jun 21
3
Dan Oren
16 Feb 21
SC 13G/A
Protalix BioTherapeutics, Inc.
16 Feb 21
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Nov 22 | Dexcel Pharma Technologies | Common Shares | Buy | Acquire P | No | No | 5 | 4,000,000 | 20.00 mm | 102,849,443 |